The National Nuclear Security Administration said Thursday it had sealed follow-on agreements with three companies to complete its share of funding for their respective molybdenum-99 production projects.
The deals ensure that SHINE Medical Technologies, NorthStar…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.





